Drug Information

Drug General Information
Drug ID
D0XP4A
Former ID
DNCL002737
Drug Name
Labetuzumab I-131
Synonyms
IMMU-111
Drug Type
Antibody
Indication Colorectal cancer [ICD9: 153, 154; ICD10:C18-C21] Phase 2 [527751]
Company
Immunomedics
Target and Pathway
Target(s) Carcinoembryonic antigen-related cell adhesion molecule 5 Target Info [550467], [551006]
NetPath Pathway TGF_beta_Receptor Signaling Pathway
References
Ref 527751Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results. J Clin Oncol.2005 Sep 20;23(27):6763-70.
Ref 550467National Cancer Institute Drug Dictionary (drug id 692828).
Ref 551006Clinical pipeline report, company report or official report of Immunomedics.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.